Regulatory signals in Brazil, Colombia, and the UK suggest ultra-processed food is approaching an inflection analogous to tobacco in the 1980s — the scientific consensus is consolidating and the political coalition is forming.
Clinical data and observational studies from 2025 show measurable reductions in addiction behavior, anxiety symptoms, and depression markers among GLP-1 users — effects that were not the drugs' design target. The mechanism may be the most important finding in psychiatry in a generation.
For the first time, clinical interventions targeting biological aging have produced statistically significant human results — and the timeline for market availability has compressed in ways the longevity field has not yet fully communicated.
Mental health outcomes in OECD countries have worsened despite more treatment access and spending — the evidence now points to a structural failure of the current treatment model, not a funding problem.
After a decade of overhyped promises, microbiome science is producing reproducible clinical results in specific conditions. The interventions that work, and why they work, reveal a biology far stranger and more consequential than the popular science version.